Clinical Trial Record

Return to Clinical Trials

the Effect of Doctor-nurse-patient Cooperative Analgesic Linkage Program on Movement Evoked Pain


2017-11-01


2020-08-01


2020-10-01


80

Study Overview

the Effect of Doctor-nurse-patient Cooperative Analgesic Linkage Program on Movement Evoked Pain

1. To establish doctor-nurse-patient cooperative analgesic linkage program. 2. Evaluate the effect of doctor-nurse-patient cooperative analgesic linkage program on movement evoked pain after laparotomy for patients with hepatobiliary and pancreatic disease through quasi-experimental study.

Part I The establishment of doctor-nurse-patient cooperative analgesic linkage program 1. Based on literature review and clinical investigation results, initially make a doctor-nurse-patient cooperative analgesic linkage program through discussion in experts consensus meeting. 2. Using Delphi method, determine the doctor-nurse-patient cooperative analgesic linkage program after two rounds consultation. Part II Clinical application study of doctor-nurse-patient cooperative analgesic linkage program. Conduct non-randomized control study in corresponding period. 80 patients from two wards which managed by the same medical and nursing team were divided into experimental and control group. Patients in the control group were received routine post-operative analgesia pump and analgesics, and functional rehabilitation, while ones in the experimental group were received doctor-nurse-patient cooperative analgesic linkage program. Evaluate the effect of pain control during rehabilitation, adverse events during rehabilitation, patients' satisfaction of pain control.

  • Pain, Postoperative
  • Anaplasia
  • DRUG: Routine Dezocine injection
  • DRUG: Adjusted Dezocine injection
  • DRUG: Routine Dynastat or Flurbiprofen Axetil jinjection
  • DRUG: Adjusted Dynastat or Flurbiprofen Axetil jinjection
  • OTHER: postoperative rehabilitation
  • DRUG: normal analgesia pump administration
  • DRUG: adjusted analgesia pump administration
  • 2017-084

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2019-01-23  

N/A  

2020-02-11  

2019-01-28  

N/A  

2020-02-12  

2019-01-31  

N/A  

2019-04  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Non Randomized


Interventional Model:
Parallel


Masking:
Triple


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Experimental Group

Patients in the experimental group were received doctor-nurse-patient cooperative analgesic linkage program.

DRUG: Adjusted Dezocine injection

  • Dezocine 10mg were intramuscular injected at at 6:00am, 2:00pm and 10:00pm.

DRUG: Adjusted Dynastat or Flurbiprofen Axetil jinjection

  • Dynastat 40mg or Flurbiprofen Axetil 50mg were administrated intravenously at at 6:00am, 2:00pm and 10:00pm.

OTHER: postoperative rehabilitation

  • Rehabilitation was conducted at 8:00am and 2:00pm.

DRUG: adjusted analgesia pump administration

  • Dose of analgesia pump was added if needed. Add one dose of analgesia pump 10 minutes before rehabilitation.
ACTIVE_COMPARATOR: control group

Patients in the control group were received routine analgesic and functional rehabilitation.

DRUG: Routine Dezocine injection

  • Dezocine 10mg were intramuscular injected at 8:00am, 4:00pm and 12:00pm.

DRUG: Routine Dynastat or Flurbiprofen Axetil jinjection

  • Dynastat 40mg or Flurbiprofen Axetil 50mg were administrated intravenously at 9:00am, 4:00pm and 12:00pm.

OTHER: postoperative rehabilitation

  • Rehabilitation was conducted at 8:00am and 2:00pm.

DRUG: normal analgesia pump administration

  • Dose of analgesia pump was added if needed.
Primary Outcome MeasuresMeasure DescriptionTime Frame
movement evoked pain (Numerical rating scale)Assess movement evoked pain during rehabilitation. Numerical rating scale is a common pain rating scale. The score ranges from 0 to 10. 0 is no pain, 10 is the most severe pain.Each rehabilitation within 3 days after surgery
pain at rest (Numerical rating scale)Assess pain at rest before rehabilitation.Numerical rating scale is a common pain rating scale. The score ranges from 0 to 10. 0 is no pain, 10 is the most severe pain.Each rehabilitation within 3 days after surgery
Secondary Outcome MeasuresMeasure DescriptionTime Frame
satisfaction questionare of pain controlPatients answer the questionare and rate the satisfaction of pain control. The questionnaire includes 7 items indicating different aspect of pain control. Patients rate their satisfaction using score. The score ranges from 1 to 5. 1 is extremely not satisfied, 5 is extremely satisfied.three days after surgery
the time of first bowel movementRecord the time of first bowel movement after surgerythree days after surgery
total dose of analgesicsrecord and calculate the total dose of analgesicsthree days after surgery
pain at night (Numerical rating scale)Asess the pain at rest during night.Numerical rating scale is a common pain rating scale. The score ranges from 0 to 10. 0 is no pain, 10 is the most severe pain.three days after surgery
adverse events during rehabilitationadverse events during rehabilitation, such as nausea, vomiting, headache, fallsthree days after surgery

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Caijuan Xu, master

Phone Number: 057187783887

Email: xucaijuan@zju.edu.cn

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Consent to the study.
  • Normal cognitive ability and speak Chinese
  • Patients received selective laparotomy under general anesthesia.
  • Length of stay is longer than three days.
  • Patients who are allowed to do rehabilitation.

  • Exclusion Criteria:

  • Patients with Severe organic disease, chronic pain, history of brain injury, history of drug or alcohol addiction.
  • Psychiatric patients
  • Consciousness disorder
  • Patients contradict to opioid medications

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Caijuan Xu, master, Second Affiliated Hospital, School of Medicine, Zhejiang University

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available